Fresenius Kabi AG Release: Acetylcysteine Solution, USP 20% In 4 ML Vials Now Available

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA announced today it has launched for immediate availability Acetylcysteine Solution, USP, 20% 4 mL vial for inhalation (mucolytic agent) or oral administration (acetaminophen antidote). Acetylcysteine Solution, USP, has been on the U.S. Food and Drug Administration and the American Society of Health-System Pharmacists’ drug shortage lists since 2011.

Help employers find you! Check out all the jobs and post your resume.